| 1Tryptic Digest of Infliximab |
|---|
search
Applications
Infliximab Peptide Mapping with Tryptic Digest on bioZen 2.6 µm Peptide XB-C18
25056
Separation Mode: Reversed Phase
Reversed Phase
PEPTIDE XB-C18
HPLC
Pharmaceutical/Biopharmaceutical
Therapeutic / Clinical
Therapeutic / Clinical
Analytes
Details
LC Conditions (App ID: 25056)
Column: |
Brand Name: bioZen |
Part No: |
Phase Name: PEPTIDE XB-C18 |
System: Agilent Technologies 1290 Infinity Agilent Technologies 1290 Infinity |
Sample Note: 1% acetonitrile, 0.1% formic acid in water |
Similar Applications
No Data
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.